先健科技公司（股票代码：1302.HK）宣布，计划通过发行可转换债券的方式，收购思达医疗科技公司96.46%的股权。此项交易旨在进一步整合医疗技术资源，拓展公司在相关领域的业务布局。市场分析人士指出，此次收购若顺利完成，或将增强先健科技在医疗器械细分市场的竞争力，并为其带来新的增长动力。具体交易条款及后续进展有待公司进一步披露。
先健科技公司（股票代码：1302.HK）宣布，计划通过发行可转换债券的方式，收购思达医疗科技公司96.46%的股权。此项交易旨在进一步整合医疗技术资源，拓展公司在相关领域的业务布局。市场分析人士指出，此次收购若顺利完成，或将增强先健科技在医疗器械细分市场的竞争力，并为其带来新的增长动力。具体交易条款及后续进展有待公司进一步披露。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.